about
Studies of B 0 − B 0 mixing properties with inclusive dilepton eventsImproved measurements of the partial rate asymmetry in B → h h decaysRoadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization.A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.Assessing the Clinical Impact of Approximations in Analytical Dose Calculations for Proton Therapy.Extension of TOPAS for the simulation of proton radiation effects considering molecular and cellular endpoints.Automated Monte Carlo Simulation of Proton Therapy Treatment Plans.SU-E-T-473: Performance Assessment of the TOPAS Tool for Particle Simulation for Proton Therapy Applications.Mechanistic Modelling of DNA Repair and Cellular Survival Following Radiation-Induced DNA Damage.Relative biological effectiveness (RBE) and out-of-field cell survival responses to passive scattering and pencil beam scanning proton beam deliveries.SU-E-T-500: Pencil-Beam versus Monte Carlo Based Dose Calculation for Proton Therapy Patients with Complex Geometries. Clinical Use of the TOPAS Monte Carlo System.A general mechanistic model enables predictions of the biological effectiveness of different qualities of radiation.Site-specific range uncertainties caused by dose calculation algorithms for proton therapy.Gold nanoparticle induced vasculature damage in radiotherapy: Comparing protons, megavoltage photons, and kilovoltage photons.Flagged uniform particle splitting for variance reduction in proton and carbon ion track-structure simulations.SU-E-T-475: Nano-Dosimetric Track Structure Scoring including Biological Modeling with TOPAS-NBio.Time-resolved diode dosimetry calibration through Monte Carlo modeling for in vivo passive scattered proton therapy range verification.Correction: Dependence of gold nanoparticle radiosensitization on cell geometry.Range uncertainty in proton therapy due to variable biological effectiveness.Upper bound on the decay tau-->microgamma from the Belle detector.Biological and dosimetric characterisation of spatially fractionated proton minibeams.Limitations of analytical dose calculations for small field proton radiosurgery.Recent developments and comprehensive evaluations of a GPU-based Monte Carlo package for proton therapy.Validation of a GPU-based Monte Carlo code (gPMC) for proton radiation therapy: clinical cases study.MO-F-BRB-03: A Method to Assess the Need for Clinical Monte Carlo Dose Calculations for Small Proton Therapy Fields.SU-E-T-470: Comparison of Proton Treatment Planning and Monte Carlo Calculation Using TOPAS for Liver Cancer.Assessing the radiation-induced second cancer risk in proton therapy for pediatric brain tumors: the impact of employing a patient-specific aperture in pencil beam scanning.Monte Carlo simulation of chemistry following radiolysis with TOPAS-nBio.Comparing gold nano-particle enhanced radiotherapy with protons, megavoltage photons and kilovoltage photons: a Monte Carlo simulation.Measurement of inclusive radiative B-meson decays with a photon energy threshold of 1.7 GeV.Evidence for neutral B meson decays to omegaK*0.Measurement of branching fractions, isospin, and CP-violating asymmetries for exclusive b-->dgamma modes.Observation of B_(s)(0)-->phigamma and search for B_(s)(0)-->gammagamma decays at Belle.Observation of anomalous upsilon(1S)pi+pi(-) and upsilon(2S)pi+pi(-) production near the upsilon(5S) resonance.Search for B --> h(*)nunu[over ] decays at Belle.Observation of B(0)-->D(*-)tau(+)nu(tau) decay at Belle.Measurement of the branching fraction and CP asymmetry in B+ --> rho+pi0.Observation of B0-->D*sJ(2317)+K- decay.Determining the Radiation Enhancement Effects of Gold Nanoparticles in Cells in a Combined Treatment with Cisplatin and Radiation at Therapeutic Megavoltage Energies.Observation of large CP violation and evidence for direct CP violation in B0-->pi(+)pi(-) decays.
P50
Q27342600-02321979-364B-464B-B82C-1B0011766DFEQ27442162-256D9366-61DB-42FF-B3B9-A436BA67C675Q30366774-CB233A0E-DA71-4E63-9DFA-1BD099CC9206Q30370355-BFA76CEA-946E-4F10-9DD1-C1B87EDCA1DAQ35875531-ABDE951F-8F38-40DB-9629-4DCB140EB4BAQ35878652-B4611794-14F0-4492-8A73-C0992F47F9D6Q38385003-3EBB4445-D7B4-496C-AEF7-0ABF88C8602FQ38778538-7572EF1B-09B3-47D2-9DB0-032C981E3374Q38821619-DE4DD0D0-B0C0-41A4-9DEF-44F9BB0FB572Q39269104-2D61A8BC-399A-4528-887B-AC0415D91B1CQ39610865-4C7D148D-3FE7-4A75-9773-6B3291A56EB4Q41542300-C7781782-2507-4520-8224-99061DBA3F5DQ42030828-DC215A27-E2FB-4B74-8864-8E62C1D69BCDQ42130442-1D93B7A8-7CD0-4D81-ABFA-24D8B8E4A06BQ46007779-45DDC4EF-803B-4CAA-87DB-0131B55F3215Q46210275-D4CC1FAC-8CDE-4821-A467-49DC09411059Q47693527-26BD55E4-D070-4F6B-A8FA-0444D4AFD340Q48582676-B48254ED-6BC5-46DB-B1AA-052FB474FD3CQ48662579-B595AE08-AE83-441D-A87D-7F30376DE75DQ49246004-4EE87CA1-AFBC-4BD2-B69E-DAE0BE189073Q50101578-86BE4722-7646-4BB3-B0FA-DC6579B306DEQ50531461-845AF2E0-C6A0-4D10-ACF9-D837C81B4762Q50622407-B7791B9D-1B70-426A-B6B7-35314DD2B40AQ50954876-EFB29EC4-10D3-4612-B088-16A6C43CB574Q51361585-E141500C-37D3-4FFD-A558-6AC3D5913DCEQ51361782-44390D5B-1DCF-4D44-84A4-DB3702EFD4D6Q51630339-1DC9CEB1-06E3-4E0A-BFB9-5C2B44B9F732Q52309184-CCACD782-091D-4010-BC29-9F1A94C5A098Q53387807-C129F9F9-2673-461E-800A-C2B303469E20Q53474939-A6CF08E7-BE59-48E4-8298-A27B434AB116Q53520590-08F34BAE-8EB3-4644-ABEE-C9569C13CC7DQ53527213-14174057-A938-4BD2-A625-4BA9B6071302Q53538641-02DEA983-0CE1-4BEC-8CBA-A38AA1FE151DQ53538656-8AD2392C-062B-4058-A863-9E3C0B3D2074Q53550970-2AD7CB45-18A2-4E61-AA1E-BFD67F9B6EB2Q53551036-EAF37421-5990-43C4-BC76-B5AC9C418D15Q53626837-D712E873-4981-46E9-B682-789A3F68A887Q53804304-D79F27BC-F11A-4EEA-8CFA-6AC8994B7341Q54946110-18BAC2CE-3CC3-49CD-8239-824E4FDD0AC6Q55038886-C02FAC3B-E33C-4110-A870-72FADE42CB17
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jan Schuemann
@ast
Jan Schuemann
@en
Jan Schuemann
@es
Jan Schuemann
@nl
Jan Schuemann
@sl
type
label
Jan Schuemann
@ast
Jan Schuemann
@en
Jan Schuemann
@es
Jan Schuemann
@nl
Jan Schuemann
@sl
altLabel
J Schümann
@en
J. Schümann
@en
Jan Schümann
@en
Schuemann J
@en
Schümann J
@en
prefLabel
Jan Schuemann
@ast
Jan Schuemann
@en
Jan Schuemann
@es
Jan Schuemann
@nl
Jan Schuemann
@sl
P108
P106
P108
P21
P31
P496
0000-0002-7554-8818